Thermo Fisher Scientific (TMO) Minority Interest (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Minority Interest for 8 consecutive years, with $121.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Minority Interest fell 3.97% year-over-year to $121.0 million; the trailing twelve-month figure through Jun 2026 stood at $121.0 million (down 3.97% YoY), and the FY2025 full-year result was $122.0 million, up 1.67% from the prior year.
• Minority Interest steadied at $121.0 million in Q2 2026 per TMO's latest filing, from $121.0 million in the prior quarter.
• Across five years, Minority Interest topped out at $129.0 million in Q3 2025 and bottomed at $113.0 million in Q2 2022.
• Historically, Minority Interest has averaged $120.3 million across 5 years, with a median of $119.5 million in 2022.
• The sharpest annual moves came in 2025 and 2026: Minority Interest climbed 9.57% in 2025, then decreased 5.47% in 2026.
• Over 5 years, Minority Interest stood at $116.0 million in 2022, then rose by 1.72% to $118.0 million in 2023, then grew by 1.69% to $120.0 million in 2024, then grew by 1.67% to $122.0 million in 2025, then fell by 0.82% to $121.0 million in 2026.
• According to Business Quant data, Minority Interest over the past three periods registered $121.0 million, $121.0 million, and $122.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.